Core Insights - The International Medical Aesthetic Anti-Aging Conference (IMCAS) was successfully held in Shanghai from July 11 to 13, 2025, attracting nearly 200 global experts and thousands of industry professionals to discuss cutting-edge topics in plastic surgery and injectable aesthetics [1][2] - Dr. Xue Zhiqiang, a leading figure in the aesthetic field, presented innovative clinical techniques from China, emphasizing the importance of precise treatment strategies for complications arising from injectable materials [2][3] Group 1: Conference Highlights - IMCAS serves as a significant academic platform for global medical aesthetics professionals, promoting collaboration and innovation in treatment technologies [1] - The conference featured in-depth discussions on the rising incidence of complications from injectable aesthetics, particularly issues related to hyaluronic acid and collagen stimulators [3] Group 2: Dr. Xue Zhiqiang's Contributions - Dr. Xue introduced a tiered treatment strategy for complications caused by collagen stimulators, advocating for ultrasound-guided injections to precisely target problem areas [3] - His presentations highlighted the effectiveness of plasma radiofrequency ablation as a minimally invasive solution for stubborn nodules and granulomas, particularly in sensitive facial regions [3] Group 3: Industry Recognition and Achievements - According to a report by Sullivan, JunTai Medical ranked first in the number of patients treated with ultrasound-assisted repair techniques in 2024, showcasing its clinical strength and industry recognition [4] - Dr. Xue's expertise in the application of collagen stimulators has positioned him as a leading figure in the field, with his techniques being widely acknowledged by peers [6][7] Group 4: Educational Initiatives - JunTai Medical has actively promoted the ultrasound-guided repair technique through training programs, successfully conducting over 40 industry training sessions to share core operational experiences [9][10] - The company's commitment to open and shared academic practices aims to elevate the overall technical standards within the medical aesthetics industry [10] Group 5: Future Directions - JunTai Medical continues to focus on high-quality, personalized aesthetic services, integrating digital diagnosis and evidence-based medicine to enhance patient outcomes [12][13] - The company emphasizes the importance of adhering to industry standards and maintaining a patient-centered approach in its operations [13]
2025英卡思国际医美大会：俊泰医疗薛志强博士持续引领馒化修复前沿